Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
home safety concern | patient-identified hazard or worry about functioning safely at home | The patient reports home safety concern related to an unlit entry stair. | Subjective | Activities, exposure and recovery history |
host susceptibility | patient factors increase vulnerability to a specific infection | Host susceptibility was assessed from immune status, devices and prior exposures. | Assessment | Infection course, epidemiology and source attribution |
household | involving people or conditions in the home | Reports a household contact with similar respiratory symptoms. | Subjective | Sequence, exposures and use of medicines |
household clustering | similar symptoms occurring among people in the home | The patient reports household clustering after a shared weekend meal. | Subjective | Activities, exposure and recovery history |
household task limitation | difficulty with usual chores inside the home | The patient reports household task limitation most evident when lifting laundry. | Subjective | Activities, exposure and recovery history |
hydroxyitraconazole | active itraconazole metabolite measured in some drug assays | The laboratory lists hydroxyitraconazole separately on the antifungal drug report. | Objective | Drug levels - named analytes and exposure reports |
hypoalbuminemia | low albumin, relevant to binding of some drugs | The hypoalbuminemia is relevant to interpreting total phenytoin. | Assessment | Drug levels - exposure and pharmacokinetics |
immediate-release | formulation that releases drug without a designed delay or extension | The earlier level followed an immediate-release dose. | Assessment | Medication exposure, response and adverse-effect reasoning |
inactive metabolite | breakdown product without the relevant pharmacologic activity | The laboratory identified the measured compound as an inactive metabolite. | Assessment | Medication response, exposure and reconciliation |
incomplete cross-tolerance | tolerance to one drug may only partly carry over to another related drug | Incomplete cross-tolerance was considered in the specialist's opioid conversion assessment. | Assessment | Medication response, exposure and reconciliation |
individual parameter estimate | model-derived value for a specific person's pharmacokinetic parameter | The individual parameter estimate was updated after the second timed measurement. | Assessment | Drug concentrations, exposure and assay interpretation |
inducer | agent increasing activity or expression of a relevant pathway | The medication history includes an inducer recently discontinued. | Assessment | Medication exposure, response and adverse-effect reasoning |
infectious incubation period | time between acquisition of an infection and symptom onset | Infectious incubation period was compared with the dates of the suspected exposure. | Assessment | Infection course, epidemiology and source attribution |
infusion-rate history | record of actual rate changes and interruptions before sampling | The infusion-rate history was reconstructed before interpreting the concentration. | Assessment | Medication response, exposure and reconciliation |
inhalational | from breathing in a substance | Reports a brief inhalational exposure to cleaning fumes. | Subjective | Sequence, exposures and use of medicines |
inhibitor | agent reducing activity of a specified enzyme or transporter | The new prescription is listed as an inhibitor of the metabolic pathway under review. | Assessment | Medication exposure, response and adverse-effect reasoning |
intensified | became stronger | Reports that the ache intensified while climbing stairs. | Subjective | Sequence, exposures and use of medicines |
interdialytic accumulation | drug or solute builds up between dialysis sessions | Interdialytic accumulation was assessed using samples aligned to each session. | Assessment | Medication response, exposure and reconciliation |
interindividual variability | differences in a parameter among different people | The report distinguishes interindividual variability from uncertainty in this patient's estimate. | Assessment | Drug concentrations, exposure and assay interpretation |
| period when a usual treatment was not taken | Reports a one-week interruption in treatment while awaiting a refill. | Subjective | Sequence, exposures and use of medicines | |
intraindividual variability | change in a parameter or result within the same person over time | The repeated levels suggest intraindividual variability across illness episodes. | Assessment | Drug concentrations, exposure and assay interpretation |
intrapatient variability | variation within the same individual across observations | Differences in draw timing complicate estimation of intrapatient variability. | Assessment | Medication exposure, response and adverse-effect reasoning |
intrinsic clearance | capacity of an organ's eliminating machinery independent of flow and binding in the model | The report lists intrinsic clearance as a model parameter. | Assessment | Drug concentrations, exposure and assay interpretation |
itraconazole | azole antifungal for which drug and active metabolite may be reported | The itraconazole and hydroxyitraconazole results are reported individually. | Objective | Drug levels - named analytes and exposure reports |
lamotrigine | antiseizure medicine for which a concentration may be compared with an individual baseline | The lamotrigine result is listed with the patient's earlier stable value. | Objective | Drug levels - named analytes and exposure reports |